# K040803: MS-30 Femoral Stem Standard and Lateral

- Pathway: 510(k) (Special)
- Applicant: Zimmer, Inc.
- Decided: Apr 29, 2004 after 31 days
- Product code: LZO (Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented)
- Device class: 2
- Regulation: 21 CFR 888.3353
- Recalls of this device: 2 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 1 generation back to K993043 (1999). 3 ancestors in all.
8 later devices descend from it; 2 cite it directly.
0 of 12 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K993043: MS-30 Femoral Stem, Sulzer Orthopedics, Inc. (1999) Summary page 1.
- K001078: Sulzer Orthopedics MS-30 Femoral Stem, Sulzer Orthopedics, Inc. (2000) Summary page 1.
- K020713: MS-30 Lateral Femoral Stem, Sulzer Orthopedics, Inc. (2002) Summary page 1.

## Most influential descendants
- K133370: Remedy Hip Stem, Pegasus Hip Stem, Evolve Helios Hip Stem, Evolve Masters Hip Stem, Evolve Distal Centralizer, Evolve CE (2014), 5 descendants of its own
- K143184: Evolve UniPolar Head (2015), 1 descendant of its own
- K131884: Avenir Cemented Hip Stem (2013), 1 descendant of its own
- K243043: Origin™ Cemented Hip Stem (2025), 0 descendants of its own
- K201047: Fusion Taper System (2021), 0 descendants of its own

## Recalls of this device
- Sep 4, 2012 · Class II · Z-0217-2013: Zimmer Inc., is initiating a correction to the patient labels of products manufactured before March 20I0 by the Zimmer GmbH production site in Winterthur, Switzerland, after receiving four complaints 
- Sep 4, 2012 · Class II · Z-0249-2013: Zimmer Inc., is initiating a correction to the patient labels of products manufactured before March 20I0 by the Zimmer GmbH production site in Winterthur, Switzerland, after receiving four complaints 

## Indications for use
The MS-30 Femoral Stem is intended for cemented use in treatment of the following: Advanced wear of the joint due to degenerative, posttraumatic or rheumatic diseases. Fractures or vascular necroses. Status following earlier operations, such as joint reconstruction (osteotomy), arthrodesis, hemiarthroplasty of total hip prosthesis (THP).

Source page: https://510kreport.com/device/K040803
Methodology: https://510kreport.com/methodology